Decadron
In brief
- In our pharmacy, you can buy Decadron (dexamethasone) without a prescription, with delivery across the United Kingdom in 9–21 days; discreet and anonymous packaging is available.
- Decadron is used to treat inflammatory, allergic and autoimmune conditions, some oncological indications, cerebral oedema and to prevent chemotherapy-induced nausea; it is a synthetic glucocorticoid that works by binding glucocorticoid receptors and altering gene transcription to suppress inflammation and immune responses.
- The usual dose varies by indication: commonly 0.5–9 mg/day orally (split doses) for inflammation, up to 24–40 mg/day in severe cases; 6 mg daily is used in severe COVID‑19; specific uses (e.g. cerebral oedema, antiemetic regimens) use higher or protocol-defined doses.
- Administered orally (tablets, oral solution), by injection/infusion (ampoules/vials), as eye drops or as ophthalmic implant; choice depends on indication and route required.
- Onset of action is rapid: within minutes when given IV, and typically within 1–2 hours after an oral dose for systemic effects.
- Duration of action: clinical effects can persist 24–72 hours; the biological half‑life is long (around 36–54 hours) and hypothalamic–pituitary–adrenal suppression may last longer after prolonged use.
- Avoid excessive alcohol while taking Decadron — alcohol can worsen gastrointestinal irritation, increase infection risk and compound metabolic or liver-related side effects.
- The most common side effect is insomnia (other frequent effects include mood changes, increased appetite, heartburn and hyperglycaemia).
- Would you like to try Decadron without a prescription?
Basic Decadron information
- INN (international nonproprietary name): Dexamethasone
- Brand names available in the United Kingdom: Decadron, dexamethasone
- ATC code: H02AB02
- Forms and dosages: Tablets, oral solution, solution for injection, eye drops 0.1%, ophthalmic implant 700 mcg (specialist use)
- Registration status in the United Kingdom: Prescription-only medicine (POM)
- OTC / Rx classification: Prescription-only medicine (POM)
What Decadron is used for
Decadron (dexamethasone) is a synthetic glucocorticoid (ATC code H02AB02). It works by binding glucocorticoid receptors and altering gene transcription to suppress inflammation and immune responses.
It is used for rapid symptom control in acute allergic flares and severe asthma attacks, for short antiemetic courses around chemotherapy, and for cerebral oedema after neurosurgical or oncological events. Oral and injectable forms usually act within hours.
| Use | Typical onset | Typical duration |
|---|---|---|
| Oral single dose (systemic) | Within hours | 6-24 hours (depending on dose) |
| IV bolus for cerebral oedema | Within 30-60 minutes | 6-8 hours per dose; regimen continued as directed |
| Antiemetic course | Within hours | 1-4 days |
Commonly described side effects are insomnia, increased appetite, mood swings and concern about longer courses. Tapering is needed after more than two weeks of therapy.
Legal status and availability in the UK
Decadron (dexamethasone) is a prescription-only medicine (POM) in the UK, and supply follows standard NHS and private prescribing rules.
In our online pharmacy, Decadron is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.
Available forms
| Form | Route | Typical use |
|---|---|---|
| Tablets | Oral | Short courses for allergy and inflammation |
| Oral solution | Oral | Children and those unable to swallow tablets |
| Injectable vials | IV/IM | Hospital use, acute cerebral oedema |
| Eye drops 0.1% | Topical ophthalmic | GP or ophthalmology prescriptions |
| Ophthalmic implant 700 mcg | Implant | Specialist only |
Store below 25°C and protect from light.
Indications and practical dosing by condition
Common acute uses
For acute inflammatory or allergic presentations, oral doses commonly range from 0.5 mg to 9 mg per day, sometimes split into two doses.
Severe cerebral oedema commonly starts at 10 mg IV followed by 4 mg IV or IM every six hours.
As an antiemetic adjunct around chemotherapy, typical adult doses are 8–12 mg orally or IV for 1–4 days.
In critical care for severe COVID‑19 respiratory disease, dexamethasone 6 mg once daily for up to 10 days is the commonly used regimen.
Chronic and oncologic regimens
Oncology protocols vary, for example 40 mg daily for defined 4‑day cycles in some myeloma/lymphoma regimens; always follow protocol guidance.
For any course longer than two weeks, a taper is usually required to reduce adrenal insufficiency risk.
| Indication | Typical adult dose | Paediatric note | Usual duration |
|---|---|---|---|
| Allergic/Inflammatory | 0.5–9 mg/day oral | 0.02–0.3 mg/kg/day | 3–10 days |
| Cerebral Oedema | 10 mg IV then 4 mg IV/IM every 6 hours | Lower per weight/age | As directed by specialist |
| Chemo‑Induced Nausea | 8–12 mg oral or IV | Weight‑based dosing | 1–4 days |
| COVID‑19 Severe Respiratory | 6 mg daily | Adjusted in paediatrics | Up to 10 days |
| Oncology Protocols | Protocol specific (e.g., 40 mg intermittent) | Adjust by BSA or weight | Per cycle guidance |
Important: Taper after more than two weeks to avoid adrenal suppression.
For paediatric dosing use weight‑based calculations and consult specialist paediatric guidance where appropriate.
Counselling points
Key messages
Advise morning dosing where possible to reduce insomnia risk.
Warn about common side effects such as insomnia, increased appetite and mood changes.
Stress not to stop suddenly after prolonged courses and to follow taper instructions if prescribed.
For injectable discharge prescriptions, explain injection site care and safe sharps disposal.
When to seek help
Follow the taper schedule you are given and know when to call your GP or NHS 111.
- Red flags to escalate: severe mood changes, sudden breathlessness, high fever, signs of hyperglycaemia or GI bleeding.
- Advice to diabetic patients: monitor blood glucose closely and liaise with the diabetes team if readings rise.
Safety, contraindications and monitoring
Absolute and relative contraindications
Absolute contraindications include known hypersensitivity to dexamethasone and systemic fungal infections.
Live vaccines should not be given during systemic corticosteroid therapy.
Relative contraindications requiring monitoring include diabetes, peptic ulcer disease, osteoporosis, uncontrolled infections, psychiatric disorders and glaucoma.
Monitoring recommendations
Monitor at‑risk patients such as those with diabetes with baseline and periodic blood glucose checks.
For long‑term therapy consider bone health assessment and osteoporosis prophylaxis.
Review blood pressure, weight and mental health when therapy continues beyond weeks.
| Monitoring item | When |
|---|---|
| Blood glucose | Baseline if diabetic; repeat 1–4 weeks if changes expected |
| Blood pressure | Baseline and periodically during prolonged therapy |
| Bone health | Consider baseline and preventive measures for long‑term use |
Side effects
Common mild effects
Common mild effects include insomnia, mood swings, increased appetite, heartburn, headache and acne.
Manage mild effects with lifestyle advice such as taking doses in the morning and dietary guidance for appetite control.
Serious adverse events
Moderate reactions include hypertension, oedema, hyperglycaemia and delayed wound healing.
Serious events include severe psychiatric disturbance, major infection, gastrointestinal bleeding and Cushingoid features with chronic use.
| Severity | Examples | Pharmacist action |
|---|---|---|
| Green (Mild) | Insomnia, mild indigestion | Advise timing changes and self‑care |
| Yellow (Moderate) | High blood sugar, new hypertension | Contact GP for review and monitoring |
| Red (Serious) | Severe mood change, signs of sepsis, GI bleed | Advise urgent GP or 111/999 as required |
Interactions and co‑medications to watch
Major drug interactions
Enzyme inducers such as rifampicin and phenytoin can reduce dexamethasone levels.
Concomitant NSAID use increases risk of gastrointestinal bleeding.
Anticoagulant doses, notably warfarin, may need monitoring and adjustment during steroid therapy.
Non-prescription and herbal considerations
Advise patients to avoid regular NSAID use without checking with the prescriber.
Herbal inducers such as St John’s wort may reduce steroid levels and should be discussed with the clinician.
| Interaction | Severity | Recommended action |
|---|---|---|
| Rifampicin, Phenytoin | Major | Monitor clinical effect; consider dose adjustment |
| NSAIDs | Moderate | Advise gastroprotection and monitor for GI symptoms |
| Warfarin | Moderate to Major | Monitor INR closely |
Special populations: children, elderly, pregnancy and breastfeeding
Paediatric dosing and risks
Use the lowest effective dose in children and calculate dosing by weight (0.02–0.3 mg/kg/day where indicated).
Monitor growth if therapy is prolonged and consult paediatric guidance for long‑term therapy.
Pregnancy and breastfeeding considerations
Prescribe in pregnancy only when benefits outweigh risks, and follow obstetric specialist guidance for fetal indications such as lung maturation.
Dexamethasone passes into breast milk; discuss timing of doses and risk–benefit with breastfeeding mothers.
Elderly patients have increased risk of osteoporosis, delirium and hyperglycaemia and should be started on the lowest effective dose with close monitoring.
Storage and disposal
Storage and handling
Store below 25°C in a dry place and protect from light.
Do not freeze injectables and protect vials from direct sunlight.
Disposal advice
Advise patients to return sharps and unused injectables to the pharmacy for safe disposal.
Unused tablets and oral solutions should be returned via medicine take‑back schemes.
| Item | Disposal route |
|---|---|
| Sharps/Injectables | Return to pharmacy for sharps disposal |
| Tablets/Solutions | Medicine take‑back at pharmacy |
Alternatives to dexamethasone
When alternatives are considered
Alternative systemic steroids such as prednisolone, methylprednisolone or hydrocortisone when clinically indicated or when formulary rules apply.
Selection should be based on equivalent potency, route and patient comorbidities.
| Steroid | Approximate relative potency | Use case |
|---|---|---|
| Hydrocortisone | Lowest | Replacement therapy, low‑potency inflammation |
| Prednisolone | Moderate | Oral systemic therapy where prednisolone is preferred |
| Methylprednisolone | Moderate–High | IV boluses in acute care |
| Dexamethasone (Decadron) | High potency | Severe inflammation, cerebral oedema, antiemetic adjunct |
Common questions
Can I stop it suddenly? No. Stopping suddenly after prolonged use risks adrenal insufficiency; follow a taper if prescribed.
Will it raise my blood sugar? Possibly. Monitor blood glucose if diabetic and contact the diabetes team if readings rise.
Can I drink alcohol? Avoid heavy drinking. Alcohol increases GI risk and may worsen side effects.
When should I get urgent help? If you have severe mood changes or high fever, contact your GP or NHS 111. If you have black tarry stools or severe abdominal pain, go to A&E immediately.
Delivery across the United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | Greater London | 9–21 days |
| Birmingham | West Midlands | 9–21 days |
| Manchester | Greater Manchester | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Leeds | West Yorkshire | 9–21 days |
| Liverpool | Merseyside | 9–21 days |
| Bristol | South West England | 9–21 days |
| Sheffield | South Yorkshire | 9–21 days |
| Newcastle Upon Tyne | North East England | 9–21 days |
| Belfast | Northern Ireland | 9–21 days |
| Cardiff | Wales | 9–21 days |
| Nottingham | Nottinghamshire | 9–21 days |
| Southampton | South East England | 9–21 days |
